SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biolase, Inc – ‘10-Q’ for 9/30/18 – ‘EX-101.SCH’

On:  Wednesday, 11/14/18, at 3:59pm ET   ·   For:  9/30/18   ·   Accession #:  1564590-18-29550   ·   File #:  1-36385

Previous ‘10-Q’:  ‘10-Q’ on 8/13/18 for 6/30/18   ·   Next:  ‘10-Q’ on 5/10/19 for 3/31/19   ·   Latest:  ‘10-Q’ on 11/9/23 for 9/30/23   ·   31 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/14/18  Biolase, Inc                      10-Q        9/30/18   81:11M                                    ActiveDisclosure/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        10-Q Q3 2018                                        HTML    703K 
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     70K 
 3: EX-4.2      Instrument Defining the Rights of Security Holders  HTML    132K 
 4: EX-10.3     Material Contract                                   HTML     97K 
 5: EX-10.4     Material Contract                                   HTML     85K 
 6: EX-10.5     Material Contract                                   HTML     64K 
 7: EX-10.6     Material Contract                                   HTML    921K 
 8: EX-31.1     Certification -- §302 - SOA'02                      HTML     30K 
 9: EX-31.2     Certification -- §302 - SOA'02                      HTML     30K 
10: EX-32.1     Certification -- §906 - SOA'02                      HTML     24K 
11: EX-32.2     Certification -- §906 - SOA'02                      HTML     25K 
18: R1          Document and Entity Information                     HTML     47K 
19: R2          Consolidated Balance Sheets (Unaudited)             HTML    117K 
20: R3          Consolidated Balance Sheets (Unaudited)             HTML     45K 
                (Parenthetical)                                                  
21: R4          Consolidated Statements Of Operations And           HTML    103K 
                Comprehensive Loss (Unaudited)                                   
22: R5          Consolidated Statements Of Cash Flows (Unaudited)   HTML    128K 
23: R6          Description of Business and Basis of Presentation   HTML     39K 
24: R7          Summary of Significant Accounting Policies          HTML     40K 
25: R8          Revenue Recognition                                 HTML    201K 
26: R9          Stockholders' Equity                                HTML    305K 
27: R10         Inventory                                           HTML     42K 
28: R11         Property, Plant, and Equipment                      HTML     60K 
29: R12         Intangible Assets and Goodwill                      HTML     27K 
30: R13         Accrued Liabilities                                 HTML    104K 
31: R14         Lines of Credit                                     HTML     35K 
32: R15         Commitments and Contingencies                       HTML     49K 
33: R16         Segment Information                                 HTML     69K 
34: R17         Concentrations                                      HTML    102K 
35: R18         Income Taxes                                        HTML     34K 
36: R19         Subsequent Event                                    HTML     29K 
37: R20         Summary of Significant Accounting Policies          HTML     75K 
                (Policies)                                                       
38: R21         Revenue Recognition (Tables)                        HTML    192K 
39: R22         Stockholders' Equity (Tables)                       HTML    300K 
40: R23         Inventory (Tables)                                  HTML     43K 
41: R24         Property, Plant, and Equipment (Tables)             HTML     60K 
42: R25         Accrued Liabilities (Tables)                        HTML    105K 
43: R26         Commitments and Contingencies (Tables)              HTML     36K 
44: R27         Segment Information (Tables)                        HTML     70K 
45: R28         Concentrations (Tables)                             HTML    102K 
46: R29         Description of Business and Basis of Presentation   HTML     68K 
                - Additional Information (Detail)                                
47: R30         Revenue Recognition - Additional Information        HTML     36K 
                (Detail)                                                         
48: R31         Summary of Opening and Closing Balances of          HTML     42K 
                Contract Liabilities (Detail)                                    
49: R32         Summary of Disaggregation of Revenues Related to    HTML     31K 
                Geographic Areas (Detail)                                        
50: R33         Summary of Revenues Disaggregated by Timing of      HTML     32K 
                Goods and Services Transferred (Detail)                          
51: R34         Summary of Sales by End Market (Detail)             HTML     32K 
52: R35         Summary of Percentages of Sales by Product line     HTML     39K 
                (Detail)                                                         
53: R36         Stockholders' Equity - Additional Information       HTML    213K 
                (Detail)                                                         
54: R37         Classification of Compensation Expense Associated   HTML     37K 
                with Share-Based Payments (Detail)                               
55: R38         Assumptions Used in Estimating Fair Value of Stock  HTML     32K 
                Options Granted (Detail)                                         
56: R39         Summary of Option Activity (Detail)                 HTML     70K 
57: R40         Summary of Unvested Stock Option Activity (Detail)  HTML     46K 
58: R41         Cash Proceeds Along with Fair Value Disclosures     HTML     35K 
                Related to Grants, Exercises and Vested Options                  
                (Detail)                                                         
59: R42         Summary of Unvested Restricted Stock Units          HTML     49K 
                (Detail)                                                         
60: R43         Summary of Warrant Activity (Detail)                HTML     46K 
61: R44         Components of Inventory (Detail)                    HTML     33K 
62: R45         Inventory - Additional Information (Detail)         HTML     26K 
63: R46         Summary of Property, Plant, and Equipment (Detail)  HTML     47K 
64: R47         Property, Plant, and Equipment - Additional         HTML     26K 
                Information (Detail)                                             
65: R48         Intangible Assets and Goodwill - Additional         HTML     32K 
                Information (Detail)                                             
66: R49         Components of Accrued Liabilities (Detail)          HTML     45K 
67: R50         Changes in Initial Product Warranty Accrual and     HTML     40K 
                Expenses Under Initial and Extended Warranties                   
                (Detail)                                                         
68: R51         Accrued Liabilities - Additional Information        HTML     28K 
                (Detail)                                                         
69: R52         Lines of Credit - Additional Information (Detail)   HTML    123K 
70: R53         Commitments and Contingencies - Additional          HTML     57K 
                Information (Detail)                                             
71: R54         Future Minimum Rental Commitments Under Lease       HTML     32K 
                Agreements (Detail)                                              
72: R55         Segment Information - Additional Information        HTML     37K 
                (Detail)                                                         
73: R56         Summary of Net Revenue by Geographic Location       HTML     31K 
                (Detail)                                                         
74: R57         Summary of Property, Plant and Equipment by         HTML     31K 
                Geographic Location (Detail)                                     
75: R58         Concentrations - Summary of Net Revenue from        HTML     52K 
                Various Products (Detail)                                        
76: R59         Concentrations - Additional Information (Detail)    HTML     39K 
77: R60         Income Taxes - Additional Information (Detail)      HTML     36K 
78: R61         Subsequent Event - Additional Information (Detail)  HTML     76K 
80: XML         IDEA XML File -- Filing Summary                      XML    135K 
79: EXCEL       IDEA Workbook of Financial Reports                  XLSX     83K 
12: EX-101.INS  XBRL Instance -- biol-20180930                       XML   2.41M 
14: EX-101.CAL  XBRL Calculations -- biol-20180930_cal               XML    151K 
15: EX-101.DEF  XBRL Definitions -- biol-20180930_def                XML    488K 
16: EX-101.LAB  XBRL Labels -- biol-20180930_lab                     XML   1.13M 
17: EX-101.PRE  XBRL Presentations -- biol-20180930_pre              XML    888K 
13: EX-101.SCH  XBRL Schema -- biol-20180930                         XSD    184K 
81: ZIP         XBRL Zipped Folder -- 0001564590-18-029550-xbrl      Zip    158K

‘EX-101.SCH’   —   XBRL Schema — biol-20180930

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- DFS ActiveDisclosure(SM) XBRL Schema Document - http://www.dfsco.com/financial-services/ -->
<!-- Creation Date : 2018-11-13T23:00:07.4742786+00:00 -->
<!-- Version : 3.1.6852.22116 -->
<!-- Package ID : a042d7cad65842ac991862478d991867 -->
<!-- Copyright (c) 2018 Donnelley Financial, LLC. All Rights Reserved. -->
<schema xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2018-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2018-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt="http://fasb.org/srt/2018-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2018-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2017-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:biol="http://www.biolase.com/20180930" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.biolase.com/20180930" xmlns="http://www.w3.org/2001/XMLSchema">
<import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
<import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
<import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
<import schemaLocation="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2018-01-31"/>
<import schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd" namespace="http://fasb.org/us-gaap/2018-01-31"/>
<import schemaLocation="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd" namespace="http://fasb.org/srt/2018-01-31"/>
<import schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-types-2018-01-31.xsd" namespace="http://fasb.org/us-types/2018-01-31"/>
<import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric"/>
<import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric"/>
<import schemaLocation="http://xbrl.fasb.org/srt/2018/elts/srt-types-2018-01-31.xsd" namespace="http://fasb.org/srt-types/2018-01-31"/>
<import schemaLocation="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" namespace="http://xbrl.sec.gov/country/2017-01-31"/>
<import schemaLocation="https://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd" namespace="http://xbrl.sec.gov/currency/2017-01-31"/>
<import schemaLocation="https://xbrl.sec.gov/exch/2018/exch-2018-01-31.xsd" namespace="http://xbrl.sec.gov/exch/2018-01-31"/>
<import schemaLocation="https://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" namespace="http://xbrl.sec.gov/invest/2013-01-31"/>
<import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31"/>
<import schemaLocation="https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31"/>
<import schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" namespace="http://xbrl.sec.gov/stpr/2018-01-31"/>
<annotation>
<appinfo>
<link:roleType id="TemplateLink" roleURI="http://www.biolase.com/20180930/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
<link:definition> 00000 - Document - Template Link </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="biol-20180930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation Links, all" xlink:type="simple" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="biol-20180930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="biol-20180930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="biol-20180930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple"/>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
<link:definition> 100000 - Document - Document and Entity Information </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" id="Role_StatementConsolidatedBalanceSheetsUnaudited">
<link:definition> 100010 - Statement - Consolidated Balance Sheets (Unaudited) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/StatementConsolidatedBalanceSheetsUnauditedParenthetical" id="Role_StatementConsolidatedBalanceSheetsUnauditedParenthetical">
<link:definition> 100020 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" id="Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited">
<link:definition> 100030 - Statement - Consolidated Statements Of Operations And Comprehensive Loss (Unaudited) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsUnaudited" id="Role_StatementConsolidatedStatementsOfCashFlowsUnaudited">
<link:definition> 100040 - Statement - Consolidated Statements Of Cash Flows (Unaudited) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentation" id="Role_DisclosureDescriptionOfBusinessAndBasisOfPresentation">
<link:definition> 100050 - Disclosure - Description of Business and Basis of Presentation </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPolicies">
<link:definition> 100060 - Disclosure - Summary of Significant Accounting Policies </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureRevenueRecognition" id="Role_DisclosureRevenueRecognition">
<link:definition> 100070 - Disclosure - Revenue Recognition </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureStockholdersEquity" id="Role_DisclosureStockholdersEquity">
<link:definition> 100080 - Disclosure - Stockholders' Equity </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureInventory" id="Role_DisclosureInventory">
<link:definition> 100090 - Disclosure - Inventory </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosurePropertyPlantAndEquipment" id="Role_DisclosurePropertyPlantAndEquipment">
<link:definition> 100100 - Disclosure - Property, Plant, and Equipment </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureIntangibleAssetsAndGoodwill" id="Role_DisclosureIntangibleAssetsAndGoodwill">
<link:definition> 100110 - Disclosure - Intangible Assets and Goodwill </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureAccruedLiabilities" id="Role_DisclosureAccruedLiabilities">
<link:definition> 100120 - Disclosure - Accrued Liabilities </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureLinesOfCredit" id="Role_DisclosureLinesOfCredit">
<link:definition> 100130 - Disclosure - Lines of Credit </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
<link:definition> 100140 - Disclosure - Commitments and Contingencies </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureSegmentInformation" id="Role_DisclosureSegmentInformation">
<link:definition> 100150 - Disclosure - Segment Information </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureConcentrations" id="Role_DisclosureConcentrations">
<link:definition> 100160 - Disclosure - Concentrations </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureIncomeTaxes" id="Role_DisclosureIncomeTaxes">
<link:definition> 100170 - Disclosure - Income Taxes </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureSubsequentEvent" id="Role_DisclosureSubsequentEvent">
<link:definition> 100180 - Disclosure - Subsequent Event </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
<link:definition> 100190 - Disclosure - Summary of Significant Accounting Policies (Policies) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureRevenueRecognitionTables" id="Role_DisclosureRevenueRecognitionTables">
<link:definition> 100200 - Disclosure - Revenue Recognition (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureStockholdersEquityTables" id="Role_DisclosureStockholdersEquityTables">
<link:definition> 100210 - Disclosure - Stockholders' Equity (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureInventoryTables" id="Role_DisclosureInventoryTables">
<link:definition> 100220 - Disclosure - Inventory (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosurePropertyPlantAndEquipmentTables" id="Role_DisclosurePropertyPlantAndEquipmentTables">
<link:definition> 100230 - Disclosure - Property, Plant, and Equipment (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureAccruedLiabilitiesTables" id="Role_DisclosureAccruedLiabilitiesTables">
<link:definition> 100240 - Disclosure - Accrued Liabilities (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" id="Role_DisclosureCommitmentsAndContingenciesTables">
<link:definition> 100250 - Disclosure - Commitments and Contingencies (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureSegmentInformationTables" id="Role_DisclosureSegmentInformationTables">
<link:definition> 100260 - Disclosure - Segment Information (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureConcentrationsTables" id="Role_DisclosureConcentrationsTables">
<link:definition> 100270 - Disclosure - Concentrations (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" id="Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail">
<link:definition> 100280 - Disclosure - Description of Business and Basis of Presentation - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetail" id="Role_DisclosureRevenueRecognitionAdditionalInformationDetail">
<link:definition> 100290 - Disclosure - Revenue Recognition - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureSummaryOfOpeningAndClosingBalancesOfContractLiabilitiesDetail" id="Role_DisclosureSummaryOfOpeningAndClosingBalancesOfContractLiabilitiesDetail">
<link:definition> 100300 - Disclosure - Summary of Opening and Closing Balances of Contract Liabilities (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureSummaryOfOpeningAndClosingBalancesOfContractLiabilitiesDetail2" id="Role_DisclosureSummaryOfOpeningAndClosingBalancesOfContractLiabilitiesDetail2">
<link:definition> 100310 - Disclosure - Summary of Opening and Closing Balances of Contract Liabilities (Detail)2 </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureSummaryOfDisaggregationOfRevenuesRelatedToGeographicAreasDetail" id="Role_DisclosureSummaryOfDisaggregationOfRevenuesRelatedToGeographicAreasDetail">
<link:definition> 100320 - Disclosure - Summary of Disaggregation of Revenues Related to Geographic Areas (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureSummaryOfRevenuesDisaggregatedByTimingOfGoodsAndServicesTransferredDetail" id="Role_DisclosureSummaryOfRevenuesDisaggregatedByTimingOfGoodsAndServicesTransferredDetail">
<link:definition> 100330 - Disclosure - Summary of Revenues Disaggregated by Timing of Goods and Services Transferred (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureSummaryOfSalesByEndMarketDetail" id="Role_DisclosureSummaryOfSalesByEndMarketDetail">
<link:definition> 100340 - Disclosure - Summary of Sales by End Market (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureSummaryOfPercentagesOfSalesByProductLineDetail" id="Role_DisclosureSummaryOfPercentagesOfSalesByProductLineDetail">
<link:definition> 100350 - Disclosure - Summary of Percentages of Sales by Product line (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail" id="Role_DisclosureStockholdersEquityAdditionalInformationDetail">
<link:definition> 100360 - Disclosure - Stockholders' Equity - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureClassificationOfCompensationExpenseAssociatedWithShareBasedPaymentsDetail" id="Role_DisclosureClassificationOfCompensationExpenseAssociatedWithShareBasedPaymentsDetail">
<link:definition> 100370 - Disclosure - Classification of Compensation Expense Associated with Share-Based Payments (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureAssumptionsUsedInEstimatingFairValueOfStockOptionsGrantedDetail" id="Role_DisclosureAssumptionsUsedInEstimatingFairValueOfStockOptionsGrantedDetail">
<link:definition> 100380 - Disclosure - Assumptions Used in Estimating Fair Value of Stock Options Granted (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureSummaryOfOptionActivityDetail" id="Role_DisclosureSummaryOfOptionActivityDetail">
<link:definition> 100390 - Disclosure - Summary of Option Activity (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureSummaryOfUnvestedStockOptionActivityDetail" id="Role_DisclosureSummaryOfUnvestedStockOptionActivityDetail">
<link:definition> 100400 - Disclosure - Summary of Unvested Stock Option Activity (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureCashProceedsAlongWithFairValueDisclosuresRelatedToGrantsExercisesAndVestedOptionsDetail" id="Role_DisclosureCashProceedsAlongWithFairValueDisclosuresRelatedToGrantsExercisesAndVestedOptionsDetail">
<link:definition> 100410 - Disclosure - Cash Proceeds Along with Fair Value Disclosures Related to Grants, Exercises and Vested Options (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureSummaryOfUnvestedRestrictedStockUnitsDetail" id="Role_DisclosureSummaryOfUnvestedRestrictedStockUnitsDetail">
<link:definition> 100420 - Disclosure - Summary of Unvested Restricted Stock Units (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureSummaryOfWarrantActivityDetail" id="Role_DisclosureSummaryOfWarrantActivityDetail">
<link:definition> 100430 - Disclosure - Summary of Warrant Activity (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureComponentsOfInventoryDetail" id="Role_DisclosureComponentsOfInventoryDetail">
<link:definition> 100440 - Disclosure - Components of Inventory (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureInventoryAdditionalInformationDetail" id="Role_DisclosureInventoryAdditionalInformationDetail">
<link:definition> 100450 - Disclosure - Inventory - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureSummaryOfPropertyPlantAndEquipmentDetail" id="Role_DisclosureSummaryOfPropertyPlantAndEquipmentDetail">
<link:definition> 100460 - Disclosure - Summary of Property, Plant, and Equipment (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosurePropertyPlantAndEquipmentAdditionalInformationDetail" id="Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetail">
<link:definition> 100470 - Disclosure - Property, Plant, and Equipment - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureIntangibleAssetsAndGoodwillAdditionalInformationDetail" id="Role_DisclosureIntangibleAssetsAndGoodwillAdditionalInformationDetail">
<link:definition> 100480 - Disclosure - Intangible Assets and Goodwill - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureComponentsOfAccruedLiabilitiesDetail" id="Role_DisclosureComponentsOfAccruedLiabilitiesDetail">
<link:definition> 100490 - Disclosure - Components of Accrued Liabilities (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureChangesInInitialProductWarrantyAccrualAndExpensesUnderInitialAndExtendedWarrantiesDetail" id="Role_DisclosureChangesInInitialProductWarrantyAccrualAndExpensesUnderInitialAndExtendedWarrantiesDetail">
<link:definition> 100500 - Disclosure - Changes in Initial Product Warranty Accrual and Expenses Under Initial and Extended Warranties (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureAccruedLiabilitiesAdditionalInformationDetail" id="Role_DisclosureAccruedLiabilitiesAdditionalInformationDetail">
<link:definition> 100510 - Disclosure - Accrued Liabilities - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureLinesOfCreditAdditionalInformationDetail" id="Role_DisclosureLinesOfCreditAdditionalInformationDetail">
<link:definition> 100520 - Disclosure - Lines of Credit - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" id="Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail">
<link:definition> 100530 - Disclosure - Commitments and Contingencies - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureFutureMinimumRentalCommitmentsUnderLeaseAgreementsDetail" id="Role_DisclosureFutureMinimumRentalCommitmentsUnderLeaseAgreementsDetail">
<link:definition> 100540 - Disclosure - Future Minimum Rental Commitments Under Lease Agreements (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureSegmentInformationAdditionalInformationDetail" id="Role_DisclosureSegmentInformationAdditionalInformationDetail">
<link:definition> 100550 - Disclosure - Segment Information - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureSummaryOfNetRevenueByGeographicLocationDetail" id="Role_DisclosureSummaryOfNetRevenueByGeographicLocationDetail">
<link:definition> 100560 - Disclosure - Summary of Net Revenue by Geographic Location (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureSummaryOfPropertyPlantAndEquipmentByGeographicLocationDetail" id="Role_DisclosureSummaryOfPropertyPlantAndEquipmentByGeographicLocationDetail">
<link:definition> 100570 - Disclosure - Summary of Property, Plant and Equipment by Geographic Location (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureConcentrationsSummaryOfNetRevenueFromVariousProductsDetail" id="Role_DisclosureConcentrationsSummaryOfNetRevenueFromVariousProductsDetail">
<link:definition> 100580 - Disclosure - Concentrations - Summary of Net Revenue from Various Products (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureConcentrationsAdditionalInformationDetail" id="Role_DisclosureConcentrationsAdditionalInformationDetail">
<link:definition> 100590 - Disclosure - Concentrations - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" id="Role_DisclosureIncomeTaxesAdditionalInformationDetail">
<link:definition> 100600 - Disclosure - Income Taxes - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.biolase.com/20180930/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetail" id="Role_DisclosureSubsequentEventAdditionalInformationDetail">
<link:definition> 100610 - Disclosure - Subsequent Event - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
</appinfo>
</annotation>
<element id="biol_ContractWithCustomerLiabilityInUndeliveredElements" name="ContractWithCustomerLiabilityInUndeliveredElements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
<element id="biol_ContractWithCustomerLiabilityInExtendedWarrantyContracts" name="ContractWithCustomerLiabilityInExtendedWarrantyContracts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
<element id="biol_ContractWithCustomerLiabilityInDeferredRoyalties" name="ContractWithCustomerLiabilityInDeferredRoyalties" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
<element id="biol_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_CustomerDepositsLiabilitiesCurrent" name="CustomerDepositsLiabilitiesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
<element id="biol_ProductsAndServicesRevenue" name="ProductsAndServicesRevenue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
<element id="biol_LicenseFeesAndRoyaltyRevenue" name="LicenseFeesAndRoyaltyRevenue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
<element id="biol_IncreaseDecreaseInCustomerDepositsLiabilities" name="IncreaseDecreaseInCustomerDepositsLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<element id="biol_LiquidityAndManagementPlansPolicyTextBlock" name="LiquidityAndManagementPlansPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_ReverseStockSplitPolicyPolicyTextBlock" name="ReverseStockSplitPolicyPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_SummaryOfRevenuesDisaggregatedByTimingOfGoodsAndServicesTransferredTableTextBlock" name="SummaryOfRevenuesDisaggregatedByTimingOfGoodsAndServicesTransferredTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_SummaryOfSalesByEndMarketTableTextBlock" name="SummaryOfSalesByEndMarketTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_SummaryOfPercentagesOfSalesByProductLineTableTextBlock" name="SummaryOfPercentagesOfSalesByProductLineTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_CashProceedsAlongWithFairValueDisclosuresRelatedToGrantsExercisesAndVestingOptionsTableTextBlock" name="CashProceedsAlongWithFairValueDisclosuresRelatedToGrantsExercisesAndVestingOptionsTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_LineOfCreditFacilityDefaultCovenantAdvance" name="LineOfCreditFacilityDefaultCovenantAdvance" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
<element id="biol_DescriptionOfBusinessAndBasisOfPresentationLineItems" name="DescriptionOfBusinessAndBasisOfPresentationLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_DescriptionOfBusinessAndBasisOfPresentationTable" name="DescriptionOfBusinessAndBasisOfPresentationTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_WesternAllianceMember" name="WesternAllianceMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_OriginalBusinessFinancingAgreementMember" name="OriginalBusinessFinancingAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_SecondModificationAgreementMember" name="SecondModificationAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_SwkFundingLlcMember" name="SwkFundingLlcMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_WorkingCapital" name="WorkingCapital" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
<element id="biol_RevenueFromProductsAndServicesTransferredToCustomersPercentage" name="RevenueFromProductsAndServicesTransferredToCustomersPercentage" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_RevenueFromServicesTransferredToCustomersOverTimePercentage" name="RevenueFromServicesTransferredToCustomersOverTimePercentage" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_ContractWithCustomerLiabilityInDeferredRoyaltiesNoncurrent" name="ContractWithCustomerLiabilityInDeferredRoyaltiesNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
<element id="biol_ContractWithCustomerLiabilityRevenueRecognizedUndeliveredElements" name="ContractWithCustomerLiabilityRevenueRecognizedUndeliveredElements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
<element id="biol_ContractWithCustomerLiabilityRevenueRecognizedExtendedWarranty" name="ContractWithCustomerLiabilityRevenueRecognizedExtendedWarranty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
<element id="biol_ContractWithCustomerLiabilityRevenueRecognizedDeferredRoyalties" name="ContractWithCustomerLiabilityRevenueRecognizedDeferredRoyalties" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
<element id="biol_PercentageOfRevenueFromContractWithCustomer" name="PercentageOfRevenueFromContractWithCustomer" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_WaterlaseMember" name="WaterlaseMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_DiodesMember" name="DiodesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_ImagingMember" name="ImagingMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_ConsumablesAndOtherMember" name="ConsumablesAndOtherMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_ServicesMember" name="ServicesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_LicenseFeesAndRoyaltiesMember" name="LicenseFeesAndRoyaltiesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_AmortizationPeriodForExpenseIncrementalCosts" name="AmortizationPeriodForExpenseIncrementalCosts" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_StockholdersEquityLineItems" name="StockholdersEquityLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_StockholdersEquityTable" name="StockholdersEquityTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_TwoThousandTwoStockIncentivePlanMember" name="TwoThousandTwoStockIncentivePlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_TwoThousandEighteenLongTermIncentivePlanMember" name="TwoThousandEighteenLongTermIncentivePlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_EmployeesMember" name="EmployeesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_PresidentAndChiefExecutiveOfficerMember" name="PresidentAndChiefExecutiveOfficerMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_ShareBasedCompensationAwardTrancheElevenMember" name="ShareBasedCompensationAwardTrancheElevenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_AwardVestingOnAugustSevenTwoThousandAndNineteenMember" name="AwardVestingOnAugustSevenTwoThousandAndNineteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_AwardVestingCommencingOnFebruarySevenTwoThousandAndTwentyMember" name="AwardVestingCommencingOnFebruarySevenTwoThousandAndTwentyMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_ShareBasedCompensationAwardTrancheTwelveMember" name="ShareBasedCompensationAwardTrancheTwelveMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_AwardVestingOnSeptemberTenTwoThousandAndNineteenMember" name="AwardVestingOnSeptemberTenTwoThousandAndNineteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_AwardVestingOnSeptemberTenTwoThousandAndTwentyMember" name="AwardVestingOnSeptemberTenTwoThousandAndTwentyMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_AwardVestingOnMarchFifteenTwoThousandAndNineteenMember" name="AwardVestingOnMarchFifteenTwoThousandAndNineteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_BoardMembersEmployeesAndConsultantsMember" name="BoardMembersEmployeesAndConsultantsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_ShareBasedCompensationAwardTrancheTenMember" name="ShareBasedCompensationAwardTrancheTenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_BoardMembersMember" name="BoardMembersMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_NewBoardMembersMember" name="NewBoardMembersMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_OriginalWesternAllianceWarrantMember" name="OriginalWesternAllianceWarrantMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_WesternAllianceWarrantMember" name="WesternAllianceWarrantMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_CommonStockIssuedPursuantToOptionsExercised" name="CommonStockIssuedPursuantToOptionsExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRestrictedStockUnitsOutstandingNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRestrictedStockUnitsOutstandingNumber" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
<element id="biol_AllocatedShareBasedCompensationExpenseCredit" name="AllocatedShareBasedCompensationExpenseCredit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<element id="biol_ShareBasedCompensationNetImpactOnEarningPerShareBasic" name="ShareBasedCompensationNetImpactOnEarningPerShareBasic" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_ShareBasedCompensationNetImpactOnEarningPerShareDiluted" name="ShareBasedCompensationNetImpactOnEarningPerShareDiluted" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_ReversalOfShareBasedCompensationExpense" name="ReversalOfShareBasedCompensationExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
<element id="biol_EngineeringAndDevelopmentMember" name="EngineeringAndDevelopmentMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividend" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividend" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAtFairMarketValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAtFairMarketValue" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedOptionsExpirationsInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedOptionsExpirationsInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_DisclosureSummaryOfOptionActivityAbstract" name="DisclosureSummaryOfOptionActivityAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAtFairMarketValue" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAtFairMarketValue" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedOptionsExpirationsInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedOptionsExpirationsInPeriodWeightedAverageExercisePrice" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingCommencementDate" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingCommencementDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDate" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_NumberOfNewBoardMembers" name="NumberOfNewBoardMembers" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
<element id="biol_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
<element id="biol_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedCancelledAndExpiredInPeriodWeightedAverageGrantDateFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedCancelledAndExpiredInPeriodWeightedAverageGrantDateFairValue" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
<element id="biol_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
<element id="biol_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriodWeightedAverageGrantDateFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriodWeightedAverageGrantDateFairValue" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
<element id="biol_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue" name="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
<element id="biol_ClassOfWarrantOrRightExpirationDate" name="ClassOfWarrantOrRightExpirationDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_ComponentsOfInventoryAbstract" name="ComponentsOfInventoryAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_PropertyPlantAndEquipmentGrossExcludingLand" name="PropertyPlantAndEquipmentGrossExcludingLand" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
<element id="biol_PropertyPlantAndEquipmentNetExcludingLand" name="PropertyPlantAndEquipmentNetExcludingLand" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
<element id="biol_ProductWarrantTerm" name="ProductWarrantTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_AccruedLiabilitiesLineItems" name="AccruedLiabilitiesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_AccruedLiabilitiesTable" name="AccruedLiabilitiesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_WaterlaseLaserSystemsMember" name="WaterlaseLaserSystemsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_DiodeSystemsMember" name="DiodeSystemsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_LineOfCreditFacilityMaximumBorrowingPercentageOfEligibleAccountsReceivable" name="LineOfCreditFacilityMaximumBorrowingPercentageOfEligibleAccountsReceivable" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
<element id="biol_DomesticRevolvingCreditFacilityMember" name="DomesticRevolvingCreditFacilityMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_ExportRevolvingCreditFacilityMember" name="ExportRevolvingCreditFacilityMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_BusinessFinancingAgreementMember" name="BusinessFinancingAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_LineOfCreditFacilityMinimumUnrestrictedCashCovenant" name="LineOfCreditFacilityMinimumUnrestrictedCashCovenant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
<element id="biol_LineOfCreditFacilityMinimumFinancialCovenant" name="LineOfCreditFacilityMinimumFinancialCovenant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
<element id="biol_VariableInterestRateWithRespectToAdvancesMade" name="VariableInterestRateWithRespectToAdvancesMade" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_InterestRateDuringPeriodInEventOfDefault" name="InterestRateDuringPeriodInEventOfDefault" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_WarrantsFairValueAssumptionsExpectedTerm" name="WarrantsFairValueAssumptionsExpectedTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_WarrantsFairValueAssumptionsExpectedVolatilityRate" name="WarrantsFairValueAssumptionsExpectedVolatilityRate" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_WarrantsFairValueAssumptionsAnnualDividendPerShare" name="WarrantsFairValueAssumptionsAnnualDividendPerShare" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
<element id="biol_WarrantsFairValueAssumptionsRiskFreeInterestRate" name="WarrantsFairValueAssumptionsRiskFreeInterestRate" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_PeriodForExtendedLease" name="PeriodForExtendedLease" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_ProvisionsForTenantImprovementAllowanceMaximum" name="ProvisionsForTenantImprovementAllowanceMaximum" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<element id="biol_LeaseFacilityArea" name="LeaseFacilityArea" type="num:areaItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
<element id="biol_CommitmentAndContingenciesLineItems" name="CommitmentAndContingenciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_CommitmentAndContingenciesTable" name="CommitmentAndContingenciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_EmployeeArrangementsAndOtherCompensationMember" name="EmployeeArrangementsAndOtherCompensationMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_FormerPresidentAndChiefExecutiveOfficerMember" name="FormerPresidentAndChiefExecutiveOfficerMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_ContractualObligationDueAfterFourthYear" name="ContractualObligationDueAfterFourthYear" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
<element id="biol_NetReductionOfStockBasedCompensationExpense" name="NetReductionOfStockBasedCompensationExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
<element id="biol_EntityWideRevenueMajorCustomerNumber" name="EntityWideRevenueMajorCustomerNumber" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_LaserSystemsMember" name="LaserSystemsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_ImagingSystemMember" name="ImagingSystemMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_ConsumableAndOtherMember" name="ConsumableAndOtherMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_EntityWideAccountsReceivableMajorCustomerNumber" name="EntityWideAccountsReceivableMajorCustomerNumber" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_SWKWarrantsMember" name="SWKWarrantsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="biol_ClassOfWarrantOrRightsExpirationDate" name="ClassOfWarrantOrRightsExpirationDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="biol_NumberOfTradingDays" name="NumberOfTradingDays" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
</schema>

31 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/19/24  Biolase, Inc.                     POS AM                 1:1.1M                                   Donnelley … Solutions/FA
 4/11/24  Biolase, Inc.                     POS AM                 3:1.1M                                   Donnelley … Solutions/FA
 3/27/24  Biolase, Inc.                     S-1/A                  5:1.1M                                   Donnelley … Solutions/FA
 3/21/24  Biolase, Inc.                     10-K       12/31/23   99:18M                                    Donnelley … Solutions/FA
 2/09/24  Biolase, Inc.                     S-1/A                  4:3M                                     Donnelley … Solutions/FA
 2/07/24  Biolase, Inc.                     S-1/A                  8:3.3M                                   Donnelley … Solutions/FA
 1/31/24  Biolase, Inc.                     S-1/A                  9:3.2M                                   Donnelley … Solutions/FA
 1/19/24  Biolase, Inc.                     S-1                    3:2.6M                                   Donnelley … Solutions/FA
12/26/23  Biolase, Inc.                     S-1                    4:496K                                   Donnelley … Solutions/FA
 9/11/23  Biolase, Inc.                     S-1/A                  4:868K                                   Donnelley … Solutions/FA
 9/05/23  Biolase, Inc.                     S-1/A       9/01/23    2:830K                                   Donnelley … Solutions/FA
 8/30/23  Biolase, Inc.                     S-1/A                  8:1.3M                                   Donnelley … Solutions/FA
 8/18/23  Biolase, Inc.                     S-1/A                  2:720K                                   Donnelley … Solutions/FA
 8/14/23  Biolase, Inc.                     S-1/A       8/11/23    8:1.3M                                   Donnelley … Solutions/FA
 7/21/23  Biolase, Inc.                     S-1                    3:800K                                   Donnelley … Solutions/FA
 5/24/23  Biolase, Inc.                     S-1/A                  7:1.2M                                   Donnelley … Solutions/FA
 5/22/23  Biolase, Inc.                     S-1/A                  8:1.3M                                   Donnelley … Solutions/FA
 5/18/23  Biolase, Inc.                     S-1/A                  8:1.2M                                   Donnelley … Solutions/FA
 5/04/23  Biolase, Inc.                     S-1                    3:750K                                   Donnelley … Solutions/FA
 3/28/23  Biolase, Inc.                     10-K       12/31/22   90:19M                                    Donnelley … Solutions/FA
 1/03/23  Biolase, Inc.                     S-1/A                  6:1M                                     Donnelley … Solutions/FA
12/12/22  Biolase, Inc.                     S-1/A                  7:1.1M                                   Donnelley … Solutions/FA
11/22/22  Biolase, Inc.                     S-1                    3:655K                                   Donnelley … Solutions/FA
 3/17/22  Biolase, Inc.                     10-K       12/31/21   88:18M                                    Donnelley … Solutions/FA
11/10/21  Biolase, Inc.                     10-Q        9/30/21   84:13M                                    Donnelley … Solutions/FA
 8/13/21  Biolase, Inc.                     10-Q        6/30/21   80:12M                                    Donnelley … Solutions/FA
 5/13/21  Biolase, Inc.                     10-Q        3/31/21   81:9.4M                                   Donnelley … Solutions/FA
 3/31/21  Biolase, Inc.                     10-K       12/31/20   88:15M                                    ActiveDisclosure/FA
12/08/20  Biolase, Inc.                     S-1/A                  3:585K                                   Donnelley … Solutions/FA
11/13/20  Biolase, Inc.                     10-Q        9/30/20   81:11M                                    ActiveDisclosure/FA
 8/14/20  Biolase, Inc.                     10-Q        6/30/20   89:12M                                    ActiveDisclosure/FA
↑Top
Filing Submission 0001564590-18-029550   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., May 7, 4:28:43.4pm ET